Krystal Biotech, Inc. (KRYS) vs Kymera Therapeutics, Inc. (KYMR)

Krystal Biotech, Inc. and Kymera Therapeutics, Inc. are both Biotechnology companies. Krystal Biotech, Inc. and Kymera Therapeutics, Inc. are of similar size ($10.2B and $9.7B). Kymera Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Krystal Biotech, Inc. trades at 41.9×. Kymera Therapeutics, Inc. grew revenue faster over the last twelve months: 134.8% against 22.6%. Krystal Biotech, Inc. has the higher net margin (54.8% vs −285.3%) and the higher return on invested capital (24.1% vs −26.7%). Across the 17 metrics below, Krystal Biotech, Inc. leads on 13 and Kymera Therapeutics, Inc. on 4.